NATCO (3)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NATCO Pharma provides clarification on ongoing litigation news, while Cipla addresses USFDA Form 483 inspectional observations at supply … | |||||||||||||||
NATCO Pharma provides clarification on ongoing litigation news, while Cipla addresses USFDA Form 483 inspectional observations at supply partner Pharmathen's Greece facility.
| |||||||||||||||
BSE circular detailing corporate actions including dividend record dates and bonus issues for multiple companies with their respective … | |||||||||||||||
BSE circular detailing corporate actions including dividend record dates and bonus issues for multiple companies with their respective ex-dates and shut periods.
| |||||||||||||||
BSE circular announcing corporate actions including dividends and bonus issues for various securities with corresponding book closure dates … | |||||||||||||||
BSE circular announcing corporate actions including dividends and bonus issues for various securities with corresponding book closure dates and shut periods for Securities Lending and Borrowing (SLB).
| |||||||||||||||